期刊文献+

中国HIV-1 B’/C亚型感染者对自身病毒中和作用与疾病进展关系的研究 被引量:2

Study on the relationships between neutralizing antibody response and disease progression of HIV type 1 B'/C infected individuals in China
下载PDF
导出
摘要 目的:探讨中国HIV-1 B’/C亚型感染者对自身病毒中和作用与疾病进展的关系。方法:将24例HIV-1 B’/C感染者自身原代病毒与同期和6个月自身血浆作用后,感染正常PBMC,培养7天测定p24抗原浓度,以正常人血浆加病毒悬液为对照。以抑制50%对照孔p24浓度的血浆最高稀释倍数的倒数计算中和抗体滴度,中和抗体滴度≥8倍为具有中和作用。结果:在同期血浆中和自身病毒试验中,3例缓慢进展者(SP)均具有中和作用,HIV组仅4例(4/21)具有中和作用,SP组中和抗体滴度明显高于HIV组。在6个月血浆中和自身病毒试验中,SP组中和抗体滴度明显增加,HIV组12例具有中和作用,SP组中和抗体滴度明显高于HIV组。中和抗体滴度与病毒载量呈明显的负相关。结论:疾病缓慢进展的HIV-1 B’/C亚型感染者对自身病毒中和作用明显高于HIV组,提示中和抗体在延缓疾病进程中发挥重要作用。 Objective:To study the relationships between neutralizing antibody response against autologous virus and disease progression of HIV-1 B'/C infected individuals in China. Methods: Twenty-four primary HIV-1 isolates were incubated with autologous plasma collected either freshly or at approximately six months intervals thereafter. Normal human peripheral blood mononuclear cells were incubated with the virus-serum mixtures for 7 days and then the production of p24 antigen was measured. The neutralizing titer of a parficular plasma and virus was defined as the reciprocal of the highest dilution giving a 50% reduction in p24 Ag compared with NHP control wells. More than 1:8 were considered significant and were scored as positive. Results: In neutralizing antibody (Nabs) response against contemporaneous virus, Nabs were produced in all slow pmgressors (SP) individuals, while only four in 21 of HIV group had. There was statistically significance of the neutralizing antibody titers between SP and HIV. When plasma samples of six months later were tested for their ability to neutralize autologous virus, all of SPs had higher neutralizing antibody titers and the tilers of neutralizing antibody in HIV group had increased in different rate. Among the twenty- one individuals of HIV group, 12 of these individuals had neutralizing antibody response against autologous virus and other 9 of these individuals had not. NAb titers of SP in six months later plasma were higher than those of HIV. There was a negative correlation between the generation of the neutralizing titer against autologous vires and the plasma HIV RNA level in HIV- 1 B'/C infected individuals ( including SP, HIV). Conclusion: Neutralizing antibody against autologous viruses in HIV-1 B'/C infected SP is higher than those of HIV group,suggesting that neutralizing antibodies play a vital role in delaying disease progression in these individuals.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2008年第6期558-562,共5页 Chinese Journal of Immunology
基金 “十五”国家科技攻关课题项目(2004BA719A12) 辽宁省科技攻关课题(2005225001) 辽宁省教育厅高等学校创新团队项目(2006T134) 国家重点基础研究发展计划(973计划)(2006CB504206)资助
关键词 HIV-1 B’/C亚型 中和抗体 疾病进展 HIV B'/C subtype Neutralizing antibedy Disease progression
  • 相关文献

参考文献14

  • 1Mc Catm C M, Song R J, Ruprecht R M. Antibodies: can they protect against HIV infection? [ J ]. Curt Drug Targets Infect Disord, 2005 ; 5 : 95- 111. 被引量:1
  • 2Devito C, Hinkula J, Kaul R et al. Cross-clade HIV- 1-specific neutralizing IgA in mucosal and systemic compartments of HIV-1-exposed, persistently seronegative subjects[J]. J Acquir Immune Defic Syndr, 2002; 30: 413- 420. 被引量:1
  • 3Broliden K, Hinkula J, Devito C et al. Functional HIV-1 specific IgA antibodies in HIV-1 exposed,persistendy IgG seronegative female sex workers [ J ]. Immunol Lett, 2001 ; 79: 29-36. 被引量:1
  • 4Barker E, Mackewicz C E, Reyes-Teran G et al. Virological and immunological features of long-term human immunodeficiency virus-infected individuals who have remained asymptomatic compared with those who have progressed to acquired immunodefieiency syndrome[J]. Blood, 1998;92: 3105-3114. 被引量:1
  • 5Bures R, Morris L, Williamson C et all. Regional clustering of shared neutralization determinants on primary isolates of clade C human immunodeficiency virus type 1 from South Africa[J] .J Virol,2002;76:2233-2244. 被引量:1
  • 6Polonis V R,de Souza M S, Darden J M et al.Human immunodeficieney virus type 1 primary isolate neutralization resistance is associated with the syncytium-inducing phenotype and lower CD4 cell counts in subtype CRF01 -AE-infected patients[ J ]. J Virol, 2003 ; 77: 8570-8576. 被引量:1
  • 7Brandful J A, Coetzer M E, Cilliers T et al. Phenotypic characterization of HIV type 1 isolates from Ghana[J] .AIDS Res Hum Retroviruses,2007; 23: 144-152. 被引量:1
  • 8Polonis V R, De Souza M S, Chanbancherd P et al. HIV type 1 subtype E- infected patients with broadened,dual (B/E) V3 loop serology have increased cross-neutralizing antibodies [ J]. AIDS Res Hum Retroviruses, 2001 ; 17:69-79. 被引量:1
  • 9Mascola J R, D' Souza P, Gilberl P et al. Recommendations for the dessign and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccines[J]. J Virol, 2005; 79:10103-10107. 被引量:1
  • 10Moore J P, Burton D R. Urgently needed: a filter for the HIV-1 vaccine pipeline[J]. Nat Med,2004; 10:769-771. 被引量:1

二级参考文献1

  • 1郑锡文.我国艾滋病流行形势与预防与控制成就[J].中国性病艾滋病防治,2000,6(3):30-35. 被引量:1

共引文献1

同被引文献10

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部